Teva $10 Billion Market Depends on New Laquinimod Test

Teva $10 Billion Market Depends on New Laquinimod Test

Adam Reynolds/Bloomberg

Teva is trying to convince investors that results for laquinimod this time will be different after earlier study outcomes sent the stock tumbling.